Breaking News

AstraZeneca COVID-19 vaccine 76% effective in new analysis of US trial

AstraZeneca said its COVID-19 vaccine was 76% effective at preventing symptomatic illness in a new analysis of its major US trial - a tad lower than the level announced earlier this week in a report that was criticised for using outdated information.

from bdnews24.com - Home https://ift.tt/31dlm34

No comments